Qiang Feng, PhD
Department of Biomedical Engineering
Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center

6000 Harry Hines Blvd, NL7.120
Dallas, Texas, 75235
Dr. Qiang Feng received his Bachelor’s (2012) and Master’s (2014) degrees in Pharmaceutics from Peking University and earned his Ph.D. (2017) in Nanoscience and Technology from the Chinese Academy of Sciences. He completed his postdoctoral training with Professor Jinming Gao at UT Southwestern, where he is now an Assistant Professor.
Dr. Feng’s research focuses on the abundance and immunological roles of key metabolites in the tumor microenvironment. By developing multi-chromatic pH nanosensors with high spatial resolution, he uncovered the presence of severely polarized extracellular acidity (pHe < 5.3) surrounding tumor cells—over an order of magnitude more extreme than previously recognized (Nature Biomedical Engineering, 2024). Integrating cancer biology, clinical insights, and immune metabolism, he demonstrated that this severe acidity acts as a potent but underappreciated immunosuppressor, while sodium lactate, its anionic counterpart, has immune-protective properties (Nature Communications, 2022). These findings led to the development of acidity-targeted immunotherapy nanodrugs and metabolism-regulating immune adjuvants.
To date, Dr. Feng has authored over 30 peer-reviewed publications in leading journals, with more than 4,000 citations, and holds three patents for his discoveries.
news
Jul 19, 2025 | New domain name registered! |
---|---|
Jul 09, 2025 | New academic page launched! ![]() ![]() |
latest posts
Jul 08, 2025 | A Microscopic Secret Tumors Tried to Keep |
---|---|
Jul 06, 2025 | Remove the Barriers |
selected publications
2024
- Nature BMESeverely polarized extracellular acidity around tumour cellsNature Biomedical Engineering, 2024
2022
- Nature CommLactate increases stemness of CD8+ T cells to augment anti-tumor immunityNature communications, 2022Qiang Feng, Zhida Liu and Xuexin Yu contributed equally
2021
- AHMTumor-Targeted Inhibition of Monocarboxylate Transporter 1 Improves T-Cell Immunotherapy of Solid TumorsAdvanced Healthcare Materials, 2021Tongyi Huang and Qiang Feng contributed equally
2019
- Accounts
2017
- SmallOne-Step Microfluidic Synthesis of Nanocomplex with Tunable Rigidity and Acid-Switchable Surface Charge for Overcoming Drug ResistanceSmall, 2017Qiang Feng and Jianping Liu contributed equally
2015
- AngewMicrofluidic synthesis of rigid nanovesicles for hydrophilic reagents deliveryAngewandte Chemie International Edition, 2015Lu Zhang, Qiang Feng, and Jiuling Wang contributed equally